Articles from Biotech Financial Reports (January 1, 2002)

Title	Author	Type	Words
AMGEN EXPECTS ACCELERATED GROWTH IN 2002 FINANCIAL RESULTS.		Brief Article	616
BRITISH BIOTECH'S SIX-MONTH LOSS DECREASED TO US$12.2M.		Statistical Data Included	1225
IMMUNE NETWORK REPORTS 9-MONTH NET LOSS OF NEARLY $9 MILLION.		Brief Article	412
NOVAMETRIX REPORTS 2ND QTR NET INCOME INCREASES 28%.		Brief Article	880